JLE

Néphrologie & Thérapeutique

MENU

Cytomegalovirus infection in the first year after pediatric kidney transplantation Volume 15, numéro 1, Mars 2019

Illustrations


  • Fig. 1

  • Fig. 2

  • Fig. 3

  • Fig. 4

Tableaux


  • Table 1

  • Table 2

  • Table 3

  • Table 4

  • Table 5

  • Table 6
Auteurs

1 IntroductionKidney transplantation (Tx) is considered the most effective treatment for children with end stage kidney disease. The drugs used to avoid transplant rejection suppress the immune system, predisposing the patient to opportunistic fungal, bacterial or viral infections [1], notably from cytomegalovirus (CMV), a ubiquitous virus from the Herpesviridae family [2,3]. Roughly 40 to 90% of humans are thought to be seropositive for CMV [2–4], with primary infection occurring mostly during childhood, [...]